Stockholders' Deficit

3 Months Ended

Mar. 31, 2026

Stockholders' Deficit

Stockholders' Deficit

9. Stockholders’ Deficit

Warrants

As of March 31, 2026, outstanding warrants to purchase shares of the Company’s Common Stock were as follows:

Shares	Exercise Price		Expiration Date
1,867,912	$	3.25	January 26, 2031
4,285,935	$	3.25	January 26, 2031
1,807,396	$	5.00	January 26, 2031
2,692,604	$	5.00	January 26, 2031
1,200	$	1,680.00	None
10,655,047

On January 23, 2026, the Company extended the expiration date of 10,653,847 warrants to January 26, 2031. The increase in the fair value of the warrants resulting from the 2026 Debt and Warrant Amendments was accounted for as part of the TDR (see Note 7 and 8).

Shares Reserved for Future Issuance

As of March 31, 2026, the Company had reserved shares of its Common Stock for future issuance as follows:

	March 31, 2026
Stock options outstanding	6,408,240
Unvested restricted stock units	135,000
Shares issuable under the Employee Stock Purchase Plan	16,174
Shares available for future grants under the 2016 Plan	3,992,177
Warrants outstanding	10,655,047
Shares issuable upon the conversion of the Convertible Loan	24,894,737
Total shares reserved	46,101,375